戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                 Before undergoing partial or total mastectomy, 213 patients with newly diagnosed brea
2                            Of women having a total mastectomy, 27% had claims from a plastic surgeon.
3 eived local therapy that consisted of either total mastectomy and axillary lymph node dissection (ALN
4  with 435 consecutive patients who underwent total mastectomy and immediate reconstruction from Janua
5 rd ratio for death among those who underwent total mastectomy and radiation as compared with those wh
6  for death among those who were treated with total mastectomy and radiation as compared with those wh
7 l review board approval, patients undergoing total mastectomy and/or axillary lymph node dissection w
8 reast cancers treated by partial mastectomy, total mastectomy, and total mastectomy with reconstructi
9 experienced surgeons, bilateral prophylactic total mastectomies combined with simultaneous bilateral
10 o 2019, the proportion of cases treated with total mastectomy decreased (eg, APC, -2.44 [95% CI, -3.4
11 ithout radiation therapy was as effective as total mastectomy for the treatment of invasive breast ca
12  or hernia repair) or breast (ie, partial or total mastectomy) general surgical procedures.
13 nt randomly assigned treatment consisting of total mastectomy, lumpectomy alone, or lumpectomy and br
14                       Bilateral prophylactic total mastectomies might be an agreeable option for thos
15 ction but with postoperative irradiation, or total mastectomy plus axillary dissection only if their
16                                              Total mastectomy rates were 18% (31 of 176) in the MRI a
17 urgical approach (partial mastectomy [PM] or total mastectomy [TM]), and BCT failure (initial PM foll
18 me to surgery was associated with older age, total mastectomy versus breast-conserving surgery, and r
19 ients undergoing initial partial mastectomy, total mastectomy was performed in 190 patients (8.5%; 95
20 iation, as compared with those who underwent total mastectomy, was 0.97 (95 percent confidence interv
21  alone, as compared with those who underwent total mastectomy, was 1.05 (95 percent confidence interv
22                               Patients had a total mastectomy with axillary dissection or segmental m
23  with axillary dissection and 88 of whom had total mastectomy with axillary dissection, were evaluate
24 st cancer (IBC) is neoadjuvant chemotherapy, total mastectomy with axillary lymph node dissection (AL
25 s of Health Consensus Conference in 1990, as total mastectomy with axillary node dissection or breast
26 undergone a modified radical mastectomy or a total mastectomy with low-axillary sampling, with negati
27 whereas the proportion of cases treated with total mastectomy with reconstruction increased (eg, APC,
28 by partial mastectomy, total mastectomy, and total mastectomy with reconstruction were calculated.
29 axillary nodes underwent radical mastectomy, total mastectomy without axillary dissection but with po
30 er underwent radical mastectomy or underwent total mastectomy without axillary dissection but with po
31 e hazard ratio for death among those who had total mastectomy without radiation as compared with thos